- Home
- GTX vs NUVB Comparison
GTX vs NUVB Comparison
Compare GTX & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GTX | NUVB |
|---|---|---|
| Founded | 2018 | 2018 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.9B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GTX | NUVB |
|---|---|---|
| Price | $17.48 | $9.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 8 |
| Target Price | ★ $20.00 | $10.63 |
| AVG Volume (30 Days) | 2.3M | ★ 6.0M |
| Earning Date | 10-23-2025 | 11-03-2025 |
| Dividend Yield | ★ 1.84% | N/A |
| EPS Growth | ★ 55.30 | N/A |
| EPS | ★ 1.57 | N/A |
| Revenue | ★ $3,537,000,000.00 | $26,748,000.00 |
| Revenue This Year | $3.71 | $609.55 |
| Revenue Next Year | $3.11 | $197.91 |
| P/E Ratio | $11.08 | ★ N/A |
| Revenue Growth | N/A | ★ 1137.19 |
| 52 Week Low | $7.02 | $1.54 |
| 52 Week High | $17.91 | $9.75 |
Technical Indicators
Market Signals| Indicator | GTX | NUVB |
|---|---|---|
| Relative Strength Index (RSI) | 61.85 | 69.97 |
| Support Level | $17.29 | $9.06 |
| Resistance Level | $17.76 | $9.75 |
| Average True Range (ATR) | 0.39 | 0.48 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 78.14 | 82.31 |
Price Performance
Historical ComparisonAbout GTX Garrett Motion Inc.
Garrett Motion Inc designs, manufactures and sells engineered turbocharger and electric-boosting technologies for light and commercial vehicle original equipment manufacturers (OEMs). The company is a technology leader with expertise in delivering products across gasoline, diesel, natural gas and electrified powertrains. The company also sells its technologies in the aftermarket through its distribution network. The company derives maximum of its revenue from Gas and geographically from Europe.
About NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.